Enhanced Recovery After Thoracic Surgery

Status Completed

Clinical Trial Summary

Despite significant advances in perioperative care, major complications continue to be seen in patients undergoing major surgery. Enhanced recovery after surgery (ERAS) protocols are perioperative care practices designed to reduce perioperative complications, maintain preoperative organ function, and provide early recovery by reducing the psychological and physiological response to major surgery and the intense stress response that develops following surgery. In this context, ERAS protocols have been established for many surgical procedures. One is the thoracic ERAS (ERATS) protocol applied to thoracic surgery, and the evidence for ERATS is increasing; literature data support the application of ERATS. However, there are limited studies on the application of ERAS protocols to thoracic surgery, and more studies are needed to develop ERATS protocols. Postoperative complications may be reduced in patients who are treated with the ERAS protocol, their length of hospital stay (LOS) may be shortened, and patients may regain their initial functions faster. Objectively, a marker indicating whether the ERAS protocol can be implemented effectively has not yet been demonstrated. Reducing postoperative inflammation is thought to reduce LOS. Based on this, the investigators think that the early recovery seen in patients who undergo ERAS is due to the effect of ERAS protocols on the inflammatory process. Therefore, laboratory parameters such as C-reactive protein (CRP), white blood cell count, neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), lymphocyte/monocytes ratio (LMR) may differ in patients who have undergone the ERAS protocol compared to patients who have not. These parameters have been evaluated comprehensively in studies as inflammatory parameters. In addition, clinical studies indicate that the C-reactive protein to albumin ratio (CAR) can be used as inflammatory and prognostic markers. Also, the investigators hypothesized that inflammatory parameters used in routine clinical follow-up may be effective in evaluating the clinical consequences of ERATS protocols. In this study, the investigators aimed to evaluate the effects of the ERATS protocol on postoperative inflammatory parameters and investigate whether these parameters have a role in evaluating the effectiveness of the ERATS protocol.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05329311
Study type	Observational
Source	Atatürk Chest Diseases and Chest Surgery Training and Research Hospital
Contact
Status	Completed
Phase
Start date	March 16, 2022
Completion date	June 16, 2022

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04865874` - GDT-PPV Protocol in Thoracic Surgery	N/A
Active, not recruiting	`NCT02715271` - Study of TB Lesions Obtained in Therapeutical Surgery
Completed	`NCT02919267` - Physiology of Lung Collapse Under One-Lung Ventilation: Underlying Mechanisms	N/A
Completed	`NCT02964026` - Study of Clinical Outcomes Associated With the Pulmonary Artery Catheter (PAC) in Cardiac Surgery Patients	N/A
Recruiting	`NCT03165539` - Cerebral Oxygen Desaturation and Post-Operative Delirium in Thoracic Surgical Patients
Terminated	`NCT01320475` - Epidural Levobupivacaine-sufentanil Versus Epidural Levobupivacaine and Intravenous Ketamine	Phase 4
Recruiting	`NCT05045196` - Health-promoting Family Conversations and Open Heart Surgery	N/A
Completed	`NCT04507958` - Electronic Stethoscope Use During Intubation in Full Personal Protective Equipment
Recruiting	`NCT05060302` - Prognosis of Right Ventricular Dysfunction Assessed by Speckle Tracking in Postoperative Thoracic Surgery	N/A
Completed	`NCT05667467` - The Effect of Care Bundle in Heart Surgery	N/A
Not yet recruiting	`NCT03275428` - THRIVE and Non-intubated Thoracic Surgery	N/A
Not yet recruiting	`NCT05482230` - Application of Tracheal Intubation in Lateral Position in Thoracic Surgery	N/A
Enrolling by invitation	`NCT04429009` - A Randomized Control Trial of ZEPHYRx Gamified Incentive Spirometry Compared to Traditional Spirometry	N/A
Not yet recruiting	`NCT03628040` - Erector Spinae Plane Block for Video-assisted Thoracoscopic Surgery	Phase 3
Recruiting	`NCT03300622` - Assessment in Patients After Thoracic Surgery	N/A
Completed	`NCT00981474` - Cerebral Autoregulation Monitoring During Cardiac Surgery	N/A
Completed	`NCT03309280` - Influence of Different Parameters on Extubation Time After Cardiac Surgery.
Recruiting	`NCT03820700` - Using Hypnosis and Virtual Reality During Pre and Postoperative Cardiovascular Surgery.	N/A
Completed	`NCT03768193` - Deep Serratus Anterior Plane Block vs Surgically-placed Paravertebral Block for VATS Surgery	N/A
Recruiting	`NCT04609228` - Cardiac Surgery Outcomes in Blood-transfusion Acceptors and no Acceptors

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.